ECTRIMS eLearning

Evaluation of pupillary response characteristics measured by pupillometry in differentiating MS from NMOSD with the machine-learning approach: a potential pupillary pattern recognition method
Author(s): ,
R. Abolfazli
Affiliations:
Department of Neurology, Amiralam Hospital, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran
,
S. Samadzadeh
Affiliations:
Department of Neurology, Academic Hospital Sozialstiftung Bamberg, Bamberg, Germany
,
B. Khorsand
Affiliations:
Department of Computer Engineering, Faculty of Engineering, Ferdowsi University of Mashhad, Mashhad
,
J. Zahiri
Affiliations:
Department of Biophysics, Bioinformatics and Computational Omics Lab (BioCOOL)
,
S.S. Arab
Affiliations:
Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran
,
S. Najafinia
Affiliations:
Mechanical Engineering Department, Amirkabir University of Technology, Tehra, Islamic Republic of Iran
,
C. Morcinek
Affiliations:
Department of Neurology, Academic Hospital Sozialstiftung Bamberg, Bamberg, Germany
P. Rieckmann
Affiliations:
Specialist Hospital for Neurology, Medical Park LOIPL, University of Erlangen, Bischofswiesen, Germany
ECTRIMS Learn. Samadzadeh S. 10/10/18; 229279; EP1441
Sara Samadzadeh
Sara Samadzadeh
Contributions
Abstract

Abstract: EP1441

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - Neuro-ophthalmology

Introduction: Pupillometry measures dynamic changes in pupillary diameter in response to light stimuli, providing a functional assessment of RGC axonal pathways in the Inflammatory Demyelinating Diseases of the Central Nervous System.
Aims: This study aimed to use machine learning technique to determine if a subset of Multiple Sclerosis (MS) patients with different disease course and Neuromyelitis Optica spectrum disorders (NMOSD) may have any distinguishing pupillary characteristics.
Methods: We analyzed Pupillometry data including neurological pupil index (Npi), pupil size (PS), minimum size of pupil (MinPS), percentage change of pupil size (CH), Constriction Velocity (CV), Maximum of Constriction Velocity (MCV), Dilation Velocity (DV) and latency (LAT) from 232 patients (169RRMS-29SPMS-21PPMS-13NMOSD).In this Cohort pupillometry parameters of 90 percent of each group is used as train and 10 remaining percent is used as a test in 10 fold cross validation for predicting the type of patients.
We have used nine base learners including Linear SVM, Poly SVM, Radial SVM, random forest, decision tree, Cart tree, K Nearest Neighbors, Naïve Bayes and RPART. Majority voting on the base learners' decisions has been used to make the final decision about each sample. This ensemble learning method achieved the total accuracy of 0.75.
Results: Among all pupillary response features Latency, Constriction Velocity (CV), Maximum of Constriction Velocity (MCV), Dilation Velocity (DV) and the discrepancy between two eyes in neurological pupil index (Npi) were more discriminative than other features according to the calculated feature importance.
Conclusions: We observed that applying machine learning technique to pupillometry data has potential to yield better discrimination of group differences. Our results may help to identify a pattern of alterations in specific pupillary parameters between MS patients with different disease course and NMOSD and may assist in clinical method planning in studies targeting pupillary light reflex pathway.
Disclosure: Prof. Rieckmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Biogen Idec, Bayer Schering Pharma, Boehringer-Ingelheim, Sanofi-Aventis, Genzyme, Novartis, Teva Pharmaceutical Industries, and Serono Symposia International Foundation.
The following authors have nothing to disclose(Roya Abolfazl, Sara Samadzadeh, Babak Khorsand, Javad Zahiri, Seyed Shahriar Arab, Siamak Najafinia, Christian Morcinek)

Abstract: EP1441

Type: Poster Sessions

Abstract Category: Clinical aspects of MS - Neuro-ophthalmology

Introduction: Pupillometry measures dynamic changes in pupillary diameter in response to light stimuli, providing a functional assessment of RGC axonal pathways in the Inflammatory Demyelinating Diseases of the Central Nervous System.
Aims: This study aimed to use machine learning technique to determine if a subset of Multiple Sclerosis (MS) patients with different disease course and Neuromyelitis Optica spectrum disorders (NMOSD) may have any distinguishing pupillary characteristics.
Methods: We analyzed Pupillometry data including neurological pupil index (Npi), pupil size (PS), minimum size of pupil (MinPS), percentage change of pupil size (CH), Constriction Velocity (CV), Maximum of Constriction Velocity (MCV), Dilation Velocity (DV) and latency (LAT) from 232 patients (169RRMS-29SPMS-21PPMS-13NMOSD).In this Cohort pupillometry parameters of 90 percent of each group is used as train and 10 remaining percent is used as a test in 10 fold cross validation for predicting the type of patients.
We have used nine base learners including Linear SVM, Poly SVM, Radial SVM, random forest, decision tree, Cart tree, K Nearest Neighbors, Naïve Bayes and RPART. Majority voting on the base learners' decisions has been used to make the final decision about each sample. This ensemble learning method achieved the total accuracy of 0.75.
Results: Among all pupillary response features Latency, Constriction Velocity (CV), Maximum of Constriction Velocity (MCV), Dilation Velocity (DV) and the discrepancy between two eyes in neurological pupil index (Npi) were more discriminative than other features according to the calculated feature importance.
Conclusions: We observed that applying machine learning technique to pupillometry data has potential to yield better discrimination of group differences. Our results may help to identify a pattern of alterations in specific pupillary parameters between MS patients with different disease course and NMOSD and may assist in clinical method planning in studies targeting pupillary light reflex pathway.
Disclosure: Prof. Rieckmann has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Biogen Idec, Bayer Schering Pharma, Boehringer-Ingelheim, Sanofi-Aventis, Genzyme, Novartis, Teva Pharmaceutical Industries, and Serono Symposia International Foundation.
The following authors have nothing to disclose(Roya Abolfazl, Sara Samadzadeh, Babak Khorsand, Javad Zahiri, Seyed Shahriar Arab, Siamak Najafinia, Christian Morcinek)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies